| Literature DB >> 30744570 |
Femke Nawijn1, Wietske H W Ham2,3, Roderick M Houwert2, Rolf H H Groenwold4, Falco Hietbrink2, Diederik P J Smeeing2.
Abstract
BACKGROUND: Emergency department utilization has increased tremendously over the past years, which is accompanied by an increased necessity for emergency medicine research to support clinical practice. Important sources of evidence are systematic reviews (SRs) and meta-analyses (MAs), but these can only be informative provided their quality is sufficiently high, which can only be assessed if reporting is adequate. The purpose of this study was to assess the quality of reporting of SRs and MAs in emergency medicine using the PRISMA statement.Entities:
Keywords: Emergency medicine; Epidemiology; Meta-analysis; Quality of reporting; Systematic review
Mesh:
Year: 2019 PMID: 30744570 PMCID: PMC6371507 DOI: 10.1186/s12873-019-0233-6
Source DB: PubMed Journal: BMC Emerg Med ISSN: 1471-227X
Fig. 1Flowchart of study selection process
Summary baseline characteristics of the included reviews
| Total | |
|---|---|
| Type of review, n (%) | |
| Systematic review | 54 (48) |
| Meta-analysis | 58 (52) |
| Year of publication, n (%) | |
| 2015 | 52 (46) |
| 2016 | 60 (54) |
| Journal, n (%) | |
| AcEM | 21 (19) |
| AEM | 10 (9) |
| Injury | 36 (32) |
| Resuscitation | 32 (28) |
| SJTREM | 13 (12) |
| Published in journal requiring PRISMA adherence, n (%) | 63 (56) |
| PRISMA use mentioned in review, n (%) | 67 (60) |
| Number of articles included in review, median (IQR) | 5 (4–6) |
| Only RCT’s included in the review, n (%) | 15 (13) |
| Author with affiliation to an epidemiology and/or statistic department, n (%) | 13 (12) |
AcEM Academic Emergency Medicine, AEM Academic Emergency Medicine, IQR InterQuartile Range, PRISMA preferred reporting items for systematic reviews and meta-analyses, RCT randomized controlled trial, SJTREM Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine
The influence of different factors on the overall PRISMA checklist adherence adjusted for type or review
| F -value | |||
|---|---|---|---|
| Total of all review, unadjusted mean ± SD | 18 ± 4 | NA | NA |
| Published in journal requiring PRISMA adherence, adjusted mean (SE) | |||
| Yes | 19.2 (0.4) | 11.0 | 0.001 |
| No | 17.2 (0.5) | ||
| PRISMA use mentioned in review, adjusted mean (SE) | |||
| Yes | 18.6 (0.4) | 1.6 | 0.214 |
| No | 17.8 (0.5) | ||
| Type of article included in review, adjusted mean (SE) | |||
| Only RCT’s | 18.2 (0.8) | 0.5 | 0.486 |
| Not limited to RCT’s | 18.8 (0.3) | ||
| Author with affiliation to a epidemiology and/or statistic department, adjusted mean (SE) | |||
| Yes | 19.9 (0.9) | 3.7 | 0.057 |
| No | 18.1 (0.3) | ||
NA not applicable, PRISMA preferred reporting items for systematic reviews and meta-analyses, RCT randomized controlled trial, SD standard deviation, SE standard error
aANCOVA correcting for type of article (systematic review or meta-analysis)
Factors influencing the adherence to each PRISMA item adjusted for type of review
| Total adherence | PRISMA mention vs. No PRISMA mention in article | Journal requiring PRISMA adherence vs. no journal requirement | |
|---|---|---|---|
| 1. Title | 93 (83) | 0.053 | 0.607 |
| 2. Structured summary | 104 (93) | 0.887 | 0.192 |
| 3. Rationale | 112 (100) | NA | NA |
| 4. Objectives | 100 (89) | 0.796 | 0.118 |
| 5. Protocol and registration | 21 (19) | 0.128 | 0.954 |
| 6. Eligibility criteria | 104 (93) | 0.622b | 0.542 |
| 7. Information sources | 96 (86) | 0.301 | 0.571 |
| 8. Search | 59 (53) | 0.270 | 0.091 |
| 9. Study selection | 90 (80) | 0.205 | 0.0202 |
| 10. Data collection process | 64 (57) | 0.431 | 0.130 |
| 11. Data items | 75 (67) | 0.701b | 0.909 |
| 12. Risk of bias in individual studies | 87 (78) | 0.352 | 0.027b.2 |
| 13. Summary measures | 63 (56) | 0.851 | 0.960 |
| 14. Synthesis of results | 79 (71) | 0.908 | 0.116 |
| 15. Risk of bias across studies | 29 (26) | 0.554 | 0.450 |
| 16. Additional analyses† | 39 (64) | 0.900 | 0.473 |
| 17. Study selection | 29 (26) | 0.002b.1 | 0.297 |
| 18. Study characteristics | 99 (88) | 0.936 | 0.0392 |
| 19. Risk of bias within studies‡ | 63 (57) | 0.989 | 0.006b.2 |
| 20. Results of individual studies | 96 (86) | 0.357 | 0.0152 |
| 21. Synthesis of results | 110 (98) | 0.657 | 0.997b |
| 22. Risk of bias across studies^ | 29 (27) | 0.791 | 0.797 |
| 23. Additional analysis˟ | 32 (55) | 0.666b | 0.706b |
| 24. Summary of evidence | 110 (98) | 0.872b | 0.997 |
| 25. Limitations | 96 (86) | 0.540 | 0.991 |
| 26. Conclusions | 84 (75) | 0.406 | 0.611 |
| 27. Funding | 87 (78) | 0.137 | < 0.0012 |
NA not applicable, PRISMA preferred reporting items for systematic reviews and meta-analysis
†51 missing cases
‡1 missing case
^4 missing cases
˟54 missing cases
1Articles with no PRISMA mention had better reporting
2Articles published in journal requiring PRISMA adherence had better reporting
aCochran-Mantel-Haenzal test used with controlling for type of study (systematic review or meta-analysis)
bLogistic regression used with controlling for type of study if Breslow-Day had p-value > 0.05